FOTIVDA: payments to doctors
Payments that named FOTIVDA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 7,783
- Transactions
- 21,380
- Average per transaction
- $88
The per-transaction average — $88 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,783 providers the average total is $241, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | $1,111,111 | 59.3% |
| AVEO Pharmaceuticals, Inc. | $763,312 | 40.7% |